articl
describ
infecti
calf
pneumonia
highmorbid
pneumonia
seen
frequent
hous
dairi
anim
mani
outbreak
occur
initi
hous
period
calv
week
month
age
howev
calv
born
spring
pastur
summer
may
also
develop
pneumonia
hous
follow
autumn
term
infecti
calf
pneumonia
gener
one
embrac
rang
pulmonari
lesion
caus
variou
microorgan
although
infecti
agent
respons
lung
damag
environment
factor
often
markedli
predispos
increas
sever
outbreak
virus
myoplasma
bacteria
involv
product
lung
damag
outbreak
investig
earli
stage
three
agent
may
demonstr
upper
lower
respiratori
tract
affect
anim
mani
virus
recov
associ
calf
pneumonia
outbreak
list
like
lengthen
futur
concurr
infect
two
virus
frequent
demonstr
outbreak
viral
activ
report
frequent
earli
stage
outbreak
acut
pneumonia
would
appear
mani
case
primari
viru
infect
initi
outbreak
produc
respiratori
tract
damag
subsequ
extend
mycoplasma
secondari
bacteri
infect
whether
viral
activ
occur
everi
outbreak
calf
pneumonia
unknown
undoubtedli
past
mani
infect
detect
improp
time
sampl
submiss
unsuit
inadequ
specimen
diagnost
laboratori
one
survey
outbreak
calf
pneumonia
investig
earli
stage
viral
activ
demonstr
per
cent
virus
frequent
recov
outbreak
calf
pneumonia
viru
viru
respiratori
syncyti
viru
rsv
bovin
viru
diarrheamucos
diseas
viru
bvdmd
viru
agent
wide
distribut
cattl
popul
countri
serolog
survey
variou
american
state
reveal
high
preval
antibodi
longitudin
studi
respiratori
viral
infect
larg
calfrear
unit
although
number
differ
viral
infect
includ
reoviru
rhinoviru
enteroviru
adenoviru
identifi
viru
rsv
infect
shown
statist
analysi
significantli
associ
outbreak
respiratori
diseas
calf
challeng
experi
shown
strain
pi
viru
rsv
produc
extens
pulmonari
consolid
inocul
calv
sever
lesion
produc
seroneg
calv
less
month
old
fig
follow
experiment
infect
rsv
replic
epitheli
cell
upper
lower
respiratori
tract
viru
may
present
nasal
secret
day
follow
infect
replic
viru
epitheli
cell
lower
respiratori
tract
caus
bronchiti
bronchiol
alveol
vari
sever
acut
stage
viru
infect
prolifer
necrosi
bronchiolar
epitheli
cell
widespread
destruct
cilia
ciliat
cell
small
bronchi
bronchioli
hyperplasia
alveolar
epitheli
cell
may
extens
epitheli
syncytia
often
form
bronchiolar
alveolar
wall
virus
infect
alveolar
macrophag
viral
interfer
alveolar
macrophag
function
may
major
predispos
factor
secondari
bacteri
pneumonia
repair
stage
sever
viru
rsv
pneumonia
widespread
organ
bronchiolar
exud
lead
format
residu
fibrou
mass
within
bronchiolar
lumina
bn
clinic
pictur
seen
mani
experiment
natur
occur
pi
rsv
infect
mild
moder
sever
howev
sever
outbreak
pneumonia
associ
rsv
combin
rsv
pi
viru
infect
also
occur
seen
commonli
fall
calv
month
old
yearl
may
affect
affect
group
per
cent
calv
may
rapidli
develop
sever
respiratori
distress
patholog
microbiolog
find
lower
respiratori
tract
sever
affect
anim
indic
extens
viru
pneumonia
bvdmd
viru
uncommonli
detect
nasal
secret
lung
calv
pneumonia
develop
antibodi
viru
may
occur
associ
outbreak
calf
pneumonia
mild
clinic
sign
respiratori
diseas
small
scatter
area
interstiti
pneumonia
observ
follow
endobronchi
inocul
calv
bvd
md
viru
numer
bacteria
present
lower
respiratori
tract
experiment
anim
indic
bvd
viru
infect
impair
bacteri
clearanc
sever
respiratori
ill
extens
fibrinopurul
pneumonia
develop
calv
sequenti
inocul
bvdmd
viru
day
later
pasteurella
haemolytica
studi
pathogenesi
bvdmd
viru
infect
bovin
respiratori
tract
rare
experiment
work
necessari
clarifi
role
viru
outbreak
calf
pneumonia
occas
adenovirus
rhinovirus
reovirus
enterovirus
herpesvirus
also
recov
outbreak
recent
coronavirus
isol
trachea
lung
young
calv
pneumonia
date
howev
except
bovin
adenoviru
type
clinic
diseas
lower
respiratori
tract
damag
produc
virus
experiment
less
sever
associ
rsv
pi
viru
bovin
herpesviru
type
infecti
bovin
rhinotrach
viru
recov
rare
pneumon
lung
young
calv
major
effect
viru
exert
upper
respiratori
tract
bovin
herpesviru
play
major
role
outbreak
calf
pneumonia
mycoplasma
frequent
recov
upper
lower
respiratori
tract
calv
earli
later
stage
pneumonia
outbreak
mycoplasma
sp
commonli
isol
pneumon
lung
dispar
bovi
ureaplasma
bovirhini
bovigenitalium
also
isol
occas
mix
infect
two
mycoplasma
sp
common
although
mycoplasma
may
also
recov
upper
sometim
lower
respiratori
tract
non
pneumon
calv
frequenc
isol
much
greater
pneumon
respiratori
tract
mycoplasma
infect
often
associ
peribronchi
peribronchiolar
lymphoid
hyperplasia
anim
speci
calv
signific
associ
note
dispar
cuf
pneumonia
pneumonia
character
expand
peribronchi
sheath
lymphoid
cell
howev
mycoplasma
includ
dispar
also
frequent
recov
lesion
acut
chronic
bronchopneumonia
calv
peribronchi
peribronchiolar
lymphoid
hyperplasia
pronounc
experiment
strain
dispar
ureaplasma
bovi
bovigenitalium
singli
combin
produc
pneumonia
inocul
lower
respiratori
tract
experiment
calv
histolog
examin
experiment
pneumonia
reveal
purul
bronchiol
variabl
degre
peribronchi
peribronchiolar
lymphoid
hyperplasia
thicken
alveolar
septa
due
cellular
infiltr
alveolar
collaps
experiment
infect
lung
lesion
produc
mycoplasma
limit
extent
clinic
sign
mild
frequent
absent
therefor
doubt
express
whether
mycoplasma
alon
absenc
viral
secondari
bacteri
infect
produc
lung
lesion
e
ompar
sever
seen
natur
occur
outbreak
synerg
demonstr
bovisand
p
haemolytica
calf
pneumonia
mechan
synergist
effect
understood
futur
studi
must
consid
viru
mycoplasma
mycoplasmabacteria
interact
bovin
lung
pathogenesi
calf
pneumonia
fulli
understood
pathogen
bacteria
play
import
role
mani
outbreak
calf
pneumonia
signific
isol
pasteurella
sp
h
aemophilu
somnu
corynebacterium
pyogen
streptobacillu
actinoid
mix
infect
uncommon
pasteurella
multocida
h
aemophilu
somnu
organ
often
recov
larg
number
lung
calv
die
sever
exud
bronchopneumonia
c
pyogen
frequent
associ
chronic
suppur
pulmonari
diseas
includ
lung
abscess
bronchiectasi
pasteurella
particularli
p
multocida
less
commonli
p
haemolytica
bacteria
consist
recov
pneumon
lung
young
calv
organ
rare
recov
lung
nonpneumon
calv
may
present
part
bacteri
flora
nasal
passag
nasopharynx
healthi
calv
role
calf
pneumonia
mainli
secondari
one
extend
increas
sever
primari
lung
damag
caus
virus
andor
mycoplasma
frequent
caus
acut
exacerb
clinic
sign
may
termin
fatal
pneumonia
uncommon
clinic
find
outbreak
salmonellosi
cattl
extens
exud
necrot
lung
lesion
note
outbreak
dublin
enterid
diseas
calv
whether
salmonella
sp
occas
capabl
produc
primari
pneumonia
calv
clear
howev
salmonellosi
superimpos
calv
preexist
pneumonia
certainli
caus
exacerb
clinic
sign
pulmonari
damag
r
epidemiolog
outbreak
pneumonia
common
group
calv
rear
indoor
problem
occur
dairi
unit
intens
beefcalf
rear
unit
cowcalf
oper
cow
calv
hous
indoor
winter
outbreak
may
occur
time
year
particularli
common
fall
earli
winter
period
season
incid
particularli
notic
viru
rsv
infect
calv
pneumonia
excret
virus
mycoplasma
nasal
secret
aerosol
produc
cough
suscept
young
calv
introduc
hous
alreadi
older
anim
pneumonia
recent
introduc
stock
infect
combin
shortrang
airborn
spread
nosetonos
contact
situat
occur
sever
dairi
farm
calv
spread
period
accommod
young
calv
limit
consequ
calv
differ
age
like
mix
togeth
airspac
outbreak
pneumonia
also
occur
batch
calv
uniform
age
introduc
hous
may
previous
disinfect
left
empti
period
may
never
held
calv
circumst
sourc
infect
harder
comprehend
sever
factor
appear
import
proport
calv
may
infect
respiratori
pathogen
earli
stage
life
pi
viru
rsv
excret
detect
colostrumf
calv
day
age
small
proport
colostrumdepriv
calv
remov
farm
birth
rais
isol
condit
excret
usual
associ
mild
sign
respiratori
diseas
may
well
miss
field
condit
viru
occas
isol
abort
bovin
fetus
antibodi
pi
viru
rsv
detect
bovin
fetal
fluid
natur
occur
pneumonia
observ
bovin
fetal
lung
lung
unsuckl
calv
hour
old
histolog
lesion
suggest
paramyxoviru
diseas
describ
udder
infect
excret
viru
milk
describ
natur
occur
viru
infect
cow
strain
involv
produc
respiratori
diseas
inocul
calv
observ
indic
congenit
earli
neonat
infect
respiratori
virus
occur
genit
udder
infect
dam
may
also
occasion
sourc
earli
bovi
ureaplasma
bovigenitalium
infect
young
calf
proport
calv
therefor
may
alreadi
infect
respiratori
pathogen
incorpor
selfcontain
group
subsequ
dissemin
infect
comrad
outbreak
pneumonia
may
occur
group
anim
togeth
week
month
histori
previou
ill
chang
manag
introduct
new
stock
sometim
experiment
isol
condit
incid
may
trigger
activ
persist
latent
viru
infect
within
respiratori
tract
factor
influenc
activ
natur
situat
fulli
understood
factor
wane
matern
antibodi
stress
sudden
temperatur
swing
chang
weather
condit
decreas
dietari
protein
intak
wean
lead
reduc
product
interferon
within
respiratori
tract
suggest
possibl
crossinfect
speci
must
also
consid
experiment
calv
success
infect
ovin
human
strain
viru
human
strain
rsv
lamb
bovin
strain
viru
rsv
produc
clinic
respiratori
diseas
pneumonia
therefor
possibl
exist
crossinfect
respiratori
virus
particularli
cattl
sheep
human
occur
natur
import
although
infecti
agent
major
factor
inflict
respiratori
tract
damag
doubt
environment
condit
import
influenc
sever
pneumonia
outbreak
although
good
hous
guarante
freedom
pneumonia
respiratori
problem
like
maximum
sever
condit
bad
hous
environment
factor
facilit
incid
spread
infecti
respiratori
diseas
includ
overcrowd
calv
airspac
inadequ
ventil
lead
buildup
microorgan
irrit
wast
gase
larg
temperatur
fluctuat
within
hous
draft
stock
level
hous
never
empti
within
therefor
persist
infect
high
incid
respiratori
diseas
young
calv
associ
cubic
airspac
less
per
calf
unit
calv
rear
usual
background
sporad
cough
particularli
evid
larg
group
anim
cough
may
associ
appar
ill
effect
calv
clinic
examin
may
reveal
littl
evid
lower
respiratori
tract
damag
instanc
may
total
extent
respiratori
problem
veterinari
attent
may
never
sought
frequent
howev
outbreak
pneumonia
occur
may
sudden
insidi
onset
veterinari
clinician
pathologist
microbiologist
may
consult
earli
late
stage
seen
group
calv
week
old
yearl
primari
outbreak
occur
group
calv
age
month
period
day
increas
frequenc
cough
sever
calv
develop
notic
tachypnea
hyperpnea
auscult
reveal
increas
harsh
lung
sound
cranioventr
serou
seropurul
nasal
discharg
common
sever
affect
anim
may
pyrex
viru
frequent
demonstr
upper
respiratori
tract
calv
stage
major
outbreak
death
uncommon
time
unless
sever
bacteri
exud
pneumonia
develop
individu
anim
fall
howev
sever
outbreak
occur
per
cent
calv
group
may
develop
sever
respiratori
distress
dyspnea
within
first
week
outbreak
fig
examin
dyspneic
anim
reveal
harsh
lung
sound
cranioventr
emphysemat
crackl
frequent
detect
subcutan
emphysema
may
palpabl
respons
antibiot
therapi
poor
fatal
occur
the
outbreak
repres
particularli
sever
form
rsv
combin
rsv
viru
infect
syndrom
first
describ
europ
term
pinkengriep
yearl
influenza
incid
howev
mean
restrict
yearl
outbreak
occur
commonli
group
calv
month
age
sacrific
cough
tachypn
calv
earli
stage
pneumonia
reveal
red
consolid
area
vari
extent
cranial
middl
accessori
lung
lobe
viru
es
mycoplasma
small
number
bacteria
may
demonstr
pneumon
lesion
earli
stage
histolog
examin
reveal
bronchiol
alveol
rsv
adenoviru
infect
present
hyperplasia
necrosi
bronchiolar
epithelium
may
promin
inclus
bodi
may
detect
bronchiolar
alveolar
epitheli
cell
rsv
infect
epitheli
syncytia
may
observ
bronchiolar
alveolar
wall
necropsi
dyspneic
calv
sever
rsv
rsv
pi
viru
pneumonia
outbreak
reveal
extens
dark
red
consolid
cranial
middl
accessori
anterior
part
caudal
lung
lobe
sever
interstiti
emphysema
subpleur
emphysema
usual
visibl
affect
lobe
larg
dissect
emphysemat
bulla
commonli
present
caudal
lobe
fig
hemorrhag
observ
surfac
lung
within
bulla
microscop
examin
reveal
sever
bron
chioliti
alveoli
ti
intens
cellular
infiltr
alveoli
alveolar
edema
thicken
interalveolar
septa
alveolar
epitheli
hyperplasia
epitheli
syncytia
contain
eosinophil
intracytoplasm
inclus
bodi
usual
observ
bronchiolar
alveolar
wall
detach
syncytia
may
seen
bronchiolar
alveolar
exud
fig
mani
small
airway
complet
plug
exud
histopatholog
chang
indic
major
viral
contribut
lower
respiratori
tract
damag
rsv
combin
ofrsv
viru
antigen
usual
demonstr
chioliti
alveol
intens
cellular
infiltr
alveoli
alveolar
edema
thicken
interalveolar
septa
alveolar
epitheli
hyperplasia
epitheli
syncytia
contain
eosinophil
intracytoplasm
inclus
bodi
usual
observ
bronchiolar
alveolar
wall
detach
syncytia
may
seen
bronchiolar
alveolar
exud
fig
mani
small
airway
complet
plug
exud
histopatholog
chang
indic
major
viral
contribut
lower
respiratori
tract
damag
rsv
combin
ofrsv
viru
antigen
usual
demonstr
lung
case
mycoplasma
bacteria
inconsist
present
lesion
similar
natur
less
extens
sever
usual
without
interstiti
emphysema
seen
nondyspn
calv
outbreak
progress
acut
pneumonia
outbreak
signific
improv
clinic
condit
nondyspn
calv
earli
stage
pneumonia
outbreak
may
follow
prompt
antibiot
therapi
treatment
tend
limit
residu
lung
damag
howev
chronic
bronchopneumonia
develop
initi
lung
damag
sever
farmer
delay
neglect
seek
veterinari
advic
sometim
even
despit
veterinari
therapi
result
extens
area
consolid
remain
lung
month
onset
outbreak
associ
chronic
cough
variabl
degre
tachypnea
hyperpnea
loss
condit
depress
feed
convers
effici
calv
chronic
bronchopneumonia
undergo
period
acut
exacerb
clinic
sign
flare
up
mani
associ
develop
sever
bacteri
exud
pneumonia
latter
case
affect
anim
depress
anorex
often
high
fever
sacrific
anim
exhibit
respiratori
sign
week
month
reveal
pneumon
area
variabl
extent
anterior
lung
lobe
widespread
fibrosi
wall
small
airway
often
appreci
grossli
purul
exud
express
airway
lumina
fibrou
adhes
may
present
adjac
lung
lobe
mediastinum
microscop
strike
chang
caus
distort
obliter
small
airway
widespread
organ
bronchiolar
exud
macrophag
fibroblast
lead
occlus
bronchiolar
lumina
fibrou
mass
fig
peribronchi
peribronchiolar
fibrosi
also
occur
variabl
amount
peribronchi
peribronchiolar
lymphoid
hyperplasia
proport
case
may
suffici
pronounc
form
lymphoid
cuff
zone
interalveolar
interlobular
fibrosi
also
occur
chang
sequela
sever
bronchiolar
alveolar
damag
occur
earli
stage
outbreak
often
extens
sever
persist
refractori
convent
therapi
mycoplasma
pasteurella
sp
may
recov
lung
stage
viral
antigen
usual
detect
mortal
due
sever
secondari
bacteri
pneumonia
may
occur
stage
calf
pneumonia
outbreak
necropsi
reveal
mark
swell
consolid
affect
lung
lobe
mild
moder
fibrin
pleurisi
usual
present
interlobular
septa
may
moder
swollen
superfici
section
bronchioli
alveoli
outlin
greyishyellow
purul
foci
larg
area
coagul
suppur
necrosi
often
visibl
section
much
purul
exud
express
small
airway
microscop
sever
exud
chang
present
particularli
within
alveoli
mark
infiltr
macrophag
neutrophil
often
format
oat
cell
necrosi
interalveolar
septa
allow
format
larg
aggreg
leukocyt
vascular
damag
mark
thrombosi
small
blood
vessel
alveolar
capillari
sever
alveolar
edema
precipit
proteinac
materi
lymphat
interlobular
septa
distend
thrombos
interlobular
edema
numer
bacteri
coloni
often
visibl
bronchiolar
alveolar
lumina
larg
number
pasteurella
h
somnu
occas
salmonella
sp
may
recov
lesion
insidi
onset
chronic
pneumonia
cuf
pneumonia
pneumonia
first
describ
worker
west
scotland
subsequ
report
calv
canada
clinic
uncompl
cuf
pneumonia
highmorbid
lowmort
pneumonia
character
frequent
harsh
cough
slight
moder
tachypnea
mild
hyperpnea
case
rhonchi
may
heard
craniaventr
although
affect
anim
alert
good
appetit
growth
rate
reduc
basi
cuf
pneumonia
lesion
hyperplasia
normal
small
amount
peribronchiolar
lymphoid
tissu
form
expand
lymphoid
cuff
surround
compress
bronchi
bronchioli
adjac
alveoli
cuf
pneumonia
found
cranioventr
segment
lung
pneumon
tissu
dark
red
purpl
pneumon
lobul
partial
collaps
hyperplast
lymphoid
tissu
may
visibl
macroscop
form
greyish
cuff
sever
millimet
diamet
surround
affect
bronchi
mention
previous
signific
associ
note
dispar
cuf
pneumonia
howev
pathogenesi
pneumonia
poorli
describ
clear
whether
mycoplasma
sole
agent
involv
genesi
lesion
cuf
pneumonia
may
becom
complic
secondari
bacteri
pneumonia
caus
p
multocida
c
pyogen
particularli
import
identifi
primari
etiolog
agent
pneumonia
outbreak
vaccin
contain
relev
pathogen
develop
effici
vaccin
program
formul
individu
farm
new
syndrom
new
infect
identifi
pathogen
mycoplasma
bacteria
recov
artifici
media
rel
eas
specimen
taken
upper
lower
respiratori
tract
pneumon
calv
detect
viral
activ
difficult
essenti
suitabl
specimen
submit
diagnost
virolog
patholog
laboratori
although
laboratori
diagnosi
respiratori
diseas
cover
separ
articl
comment
particularli
submiss
specimen
practition
relev
point
pneumonia
outbreak
possibl
diagnos
certainti
virus
mycoplasma
present
clinic
examin
alon
nevertheless
may
use
clinic
pointer
outbreak
sever
pneumonia
rapid
onset
sever
respiratori
distress
number
calv
necropsi
find
consolid
anterior
lung
lobe
sever
interstiti
emphysema
arous
suspicion
acut
rsv
rsv
pi
viru
pneumonia
pneumoenter
may
observ
bvd
viru
adenoviru
coronaviru
infect
arthriti
may
accompani
respiratori
sign
bovi
involv
demonstr
virus
mycoplasma
involv
sampl
upper
respiratori
tract
number
anim
submiss
pair
sera
ideal
submiss
one
anim
outbreak
necropsi
viru
like
detect
nasal
secret
acut
stage
pneumonia
outbreak
import
take
nasal
sampl
earli
stage
ideal
day
acut
respiratori
sign
first
note
minimum
six
anim
sampl
rang
clinic
sever
repres
nasal
swab
tampon
suction
apparatu
may
use
nasal
swab
nylon
bristl
prefer
tradit
cottonwool
swab
particularli
satisfactori
method
sampl
involv
use
portabl
vacuum
pump
extract
sampl
nasal
mucu
small
contain
epitheli
cell
separ
mucu
sampl
examin
viral
antigen
immmunofluoresc
stain
batteri
conjug
antisera
techniqu
allov
rapid
diagnosi
viru
infect
sensit
viru
isol
particularli
suitabl
detect
virus
rsv
coronaviru
extrem
difficult
isol
cell
cultur
may
present
mix
infect
rapidli
grow
virus
immunofluoresc
stain
nasal
epitheli
cell
use
detect
viru
rsv
bvdmd
viru
coronaviru
ibr
viru
infect
respiratori
tract
fig
rememb
certain
respiratori
virus
particularli
rsv
notori
labil
specimen
submit
quickli
possibl
diagnost
laboratori
demonstr
sever
anim
group
fourfold
greater
increas
viral
antibodi
titer
acut
convalesc
serum
sampl
indic
recent
infect
acut
phase
sampl
must
taken
near
possibl
time
onset
respiratori
sign
otherwis
serolog
convers
may
demonstr
convalesc
sampl
taken
anim
week
later
submiss
singl
batch
sera
unsatisfactori
serolog
diagnosi
alon
calv
less
month
old
unreli
persist
matern
antibodi
may
block
activ
serolog
respons
viral
infect
submiss
entir
anim
portion
lower
respiratori
tract
facilit
patholog
microbiolog
examin
pneumon
lung
lung
tissu
taken
submiss
diagnost
laboratori
number
sampl
select
affect
lobe
lesion
variou
stage
may
present
differ
region
lung
formalinfix
block
well
unfix
sampl
submit
histopatholog
examin
lung
particular
valu
diagnosi
acut
viral
pneumonia
associ
rsv
pi
viru
infect
diagnosi
cuf
pneumonia
sever
bacteri
exud
pneumonia
submiss
unfix
lung
specimen
allow
cultur
examin
virus
mycoplasma
bacteria
carri
also
facilit
rapid
diagnosi
viral
mycoplasm
infect
immunofluoresc
immunoperoxidas
stain
lung
impress
smear
cryostat
section
detect
viral
antigen
immunofluoresc
immunoperoxidas
stain
formalinfix
paraffin
section
lung
also
possibl
unfortun
mani
calv
submit
necropsi
pneumonia
outbreak
die
long
period
respiratori
ill
becom
stunt
uneconom
keep
mani
case
therefor
lung
damag
chronic
natur
domin
sever
bacteri
exud
chang
littl
inform
may
gain
either
patholog
microbiolog
examin
agent
respons
initi
problem
sacrific
one
calv
time
onset
diseas
consid
sever
outbreak
pneumonia
particularli
larg
number
valuabl
anim
involv
polici
provid
optim
materi
patholog
microbiolog
investig
like
result
identif
primari
etiolog
agent
acceler
develop
success
therapeut
prophylact
regimen
assess
rel
contribut
virus
mycoplasma
bacteria
lung
damag
particular
outbreak
must
made
cautious
involv
consider
agent
isol
demonstr
natur
damag
lung
respons
affect
calv
antibiot
therapi
present
effect
antivir
chemotherapeut
commerci
avail
use
calf
pneumonia
therefor
treatment
base
antibiot
therapi
direct
mycoplasm
bacteri
compon
diseas
good
invitro
activ
dispar
bovin
respiratori
calf
pneumonia
logic
convers
may
demonstr
convalesc
sampl
taken
anim
week
later
submiss
singl
batch
sera
unsatisfactori
serolog
diagnosi
alon
calv
less
month
old
unreli
persist
matern
antibodi
may
block
activ
serolog
respons
viral
infect
submiss
necropsi
materi
submiss
entir
anim
portion
lower
respiratori
tract
facilit
patholog
microbiolog
examin
pneumon
lung
lung
tissu
taken
submiss
diagnost
laboratori
number
sampl
select
affect
lobe
lesion
variou
stage
may
present
differ
region
lung
formalinfix
block
well
unfix
sampl
submit
histopatholog
examin
oflung
particular
valu
diagnosi
acut
viral
pneumonia
associ
rsv
viru
infect
diagnosi
cuf
pneumonia
sever
bacteri
exud
pneumonia
submiss
unfix
lung
specimen
allow
cultur
examin
virus
mycoplasma
bacteria
carri
also
facilit
rapid
diagnosi
viral
mycoplasm
infect
immunofluoresc
immunoperoxidas
stain
lung
impress
smear
cryostat
section
detect
viral
antigen
immunofluoresc
immunoperoxidas
stain
formalinfix
paraffin
section
lung
also
unfortun
mani
calv
submit
necropsi
pneumonia
outbreak
die
long
period
respiratori
ill
becom
stunt
uneconom
keep
mani
case
therefor
lung
damag
chronic
natur
domin
sever
bacteri
exud
chang
littl
inform
may
gain
either
patholog
microbiolog
examin
agent
respons
initi
problem
sacrific
one
calv
time
onset
diseas
consid
sever
outbreak
pneumonia
particularli
larg
number
valuabl
anim
involv
polici
provid
optim
materi
patholog
microbiolog
investig
like
result
identif
primari
etiolog
agent
acceler
develop
success
therapeut
prophylact
regimen
assess
rel
contribut
virus
mycoplasma
bacteria
lung
damag
particular
outbreak
must
made
cautious
involv
consider
agent
isol
demonstr
natur
damag
lung
respons
affect
calv
antibiot
therapi
present
effect
antivir
chemotherapeut
commerci
avail
use
calf
pneumonia
therefor
treatment
base
antibiot
therapi
direct
mycoplasm
bacteri
compon
diseas
good
invitro
activ
dispar
bovin
respiratori
tract
ureaplasma
demonstr
antibiot
tiamulin
hydrogen
fumar
tylosin
tartrat
sever
outbreak
best
treat
entir
group
antibiot
administ
parenter
rout
use
regimen
maintain
therapeut
level
lung
least
day
experi
author
combin
intramuscular
tylosin
tartrat
administ
dose
rate
mg
per
kg
daili
day
anoth
broadspectrum
antibiot
oxytetracyclin
provid
addit
activ
pasteurella
sp
often
produc
satisfactori
result
particularli
true
first
dose
oxytetracyclin
administ
intraven
rate
mg
per
kg
encourag
result
also
report
follow
use
combin
lincomycin
spectinomycin
mg
lincomycin
mg
spectinomycin
per
ml
administ
intramuscular
inject
day
rate
mg
per
kg
ml
per
kg
antibiot
therapi
like
effect
appli
earli
stage
outbreak
treat
acut
bacteri
exacerb
respiratori
qiseas
virus
play
major
role
product
lung
damag
satisfactori
clinic
respons
may
occur
period
hour
case
sever
viral
pneumonia
case
chronic
pneumonia
fibrou
bronchoocclus
lesion
lymphoid
cuf
lesion
well
establish
antibiot
therapi
lesser
impact
respons
antibiot
therapi
may
also
disappoint
case
bovi
involv
sever
affect
anim
fail
respond
antibiot
therapi
alon
commonli
treat
antiinflammatori
agent
popular
method
antiinflammatori
therapi
involv
administr
one
dose
corticosteroid
exampl
one
two
intraven
inject
dexamethason
dose
rate
mg
per
kg
corticosteroid
may
occas
caus
exacerb
viral
respiratori
tract
diseas
recent
report
indic
potenti
valu
altern
form
antiinflammatori
therapi
use
antiprostaglandin
compound
flunixin
meglumin
drug
given
intraven
dose
rate
mg
per
kg
consecut
day
markedli
reduc
sever
clinic
sign
extent
pulmonari
consolid
experiment
viru
pneumonia
calv
bronchodil
clenbuterol
etemiphyllin
mucolyt
bromhexin
hydrochlorid
also
avail
treatment
calf
pneumonia
bromhexin
hydrochlorid
administ
simultan
oxytetracyclin
level
latter
bronchial
mucu
consider
increas
unfortun
littl
detail
clinic
inform
publish
assess
efficaci
bronchodil
mucolyt
therapi
addit
provid
drug
therapi
import
identifi
possibl
remedi
hous
fault
overstock
poor
ventil
draft
may
exacerb
respiratori
problem
program
prevent
pneumonia
calfrear
unit
includ
measur
reduc
environment
stress
avoid
condit
favor
spread
infecti
respiratori
diseas
also
incorpor
specif
prophylact
measur
direct
microorgan
associ
calf
pneumonia
hous
calf
first
month
life
main
aim
provid
dri
draftfre
environ
adequ
ventil
minimum
per
hr
per
calf
cubic
air
capac
minimum
per
calf
provis
good
ventil
necessarili
involv
instal
expens
control
environ
system
adequ
provis
care
site
air
inlet
outlet
may
possibl
achiev
effect
ventil
without
draft
natur
mean
util
stack
effect
calv
month
inlet
area
per
calf
outlet
area
per
calf
outlet
place
inlet
recommend
air
inlet
situat
well
level
calf
pen
avoid
draft
whenev
possibl
calv
similar
age
rear
selfcontain
group
polici
adopt
thu
allow
period
depopul
disinfect
calf
hous
calv
present
one
airspac
one
avoid
feed
calv
mouldi
hay
dusti
meal
antibodi
bovin
respiratori
virus
viru
rsv
widespread
adult
cattl
popul
calv
provid
given
access
colostrum
suitabl
time
obtain
matern
antibodi
may
persist
serum
month
efficaci
colostr
antibodi
respiratori
diseas
first
month
calf
life
clear
howev
one
report
experiment
viru
infect
sever
clinic
sign
produc
calv
depriv
colostrum
calv
fed
colostrum
use
inocul
regimen
mani
outbreak
pneumonia
occur
time
matern
antibodi
wane
disappear
one
studi
calv
total
serum
immunoglobulin
level
excess
zinc
sulphat
turbid
test
unit
zstu
day
age
found
significantli
less
prone
fatal
nonfat
respiratori
diseas
first
month
life
calv
level
zstu
would
appear
prudent
therefor
ensur
calv
fed
adequ
amount
colostrum
earli
stage
life
pint
first
hr
even
optimum
hous
condit
sever
outbreak
pneumonia
may
still
occur
therefor
necessari
develop
effect
vaccin
program
vaccin
program
differ
farm
vari
depend
histori
respiratori
diseas
microorgan
associ
respiratori
diseas
manag
practic
farm
develop
success
program
complic
fact
number
differ
microorgan
capabl
produc
primari
pneumonia
calf
lung
mani
instanc
necessari
protect
young
age
group
calv
prioriti
present
prevent
sever
lung
damag
caus
rsv
pi
viru
hope
block
primari
pneumonia
caus
virus
opportun
mycoplasma
secondari
bacteri
infect
inflict
addit
lung
damag
also
reduc
circul
rsv
viru
occur
nearli
everi
year
rear
calv
dairi
herd
infect
common
last
month
year
calv
born
late
summer
autumn
therefor
may
experi
pi
viru
rsv
associ
pneumonia
first
month
life
contrast
calv
born
spring
pastur
summer
may
challeng
follow
autumn
winter
hous
period
month
old
prioriti
vaccin
calv
born
late
summer
autumn
achiev
rapid
onset
protect
avoid
overcom
interfer
vaccin
matern
antibodi
theoret
least
object
like
achiev
intranas
vaccin
use
live
vaccin
live
pi
vaccin
design
intranas
use
commerci
avail
safe
use
young
calv
calv
vaccin
day
week
old
booster
vaccin
necessari
week
later
ensur
persist
local
antibodi
nasal
secret
contrast
intranas
rsv
vaccin
avail
rsv
vaccin
commerci
avail
present
live
attenu
vaccin
design
intramuscular
use
primari
vaccin
regimen
product
necessit
two
inocul
given
least
week
apart
ideal
vaccin
administ
seroneg
anim
follow
primari
vaccin
regimen
manufactur
claim
durat
immun
least
month
unfortun
howev
respons
live
rsv
vaccin
given
intramuscular
rout
sever
depress
circul
matern
antibodi
also
young
calv
vaccin
anticip
diseas
problem
month
age
persist
matern
antibodi
rsv
may
interfer
take
first
inocul
vaccin
attempt
overcom
manufactur
recommend
addit
inocul
vaccin
calv
less
month
old
vaccin
calv
born
spring
pastur
summer
may
experi
rsv
diseas
autumn
spring
calv
herd
histori
seriou
respiratori
problem
earli
year
vaccin
may
delay
later
summer
period
time
calv
older
matern
antibodi
larg
disappear
major
doubleblind
field
trial
carri
netherland
use
intramuscular
live
attenu
rsv
vaccin
deriv
european
strain
rsv
trial
involv
calv
farm
respiratori
problem
due
rsv
observ
preced
year
complet
vaccin
group
incid
rsv
infect
incid
lower
respiratori
tract
diseas
due
rsv
significantli
reduc
compar
unvaccin
group
gener
mild
sign
upper
respiratori
tract
diseas
present
complet
vaccin
group
follow
rsv
infect
recent
studi
experiment
inactiv
rsv
vaccin
compar
two
live
vaccin
group
calv
age
month
calv
low
undetect
level
matern
antibodi
rsv
inactiv
vaccin
consist
glutaraldehydefix
bovin
nasal
mucosa
cell
persist
infect
rsv
emulsifi
oil
adjuv
administ
subcutan
live
vaccin
modifi
live
viru
vaccin
deriv
bovin
strain
rsv
temperaturesensit
vaccin
deriv
human
strain
rsv
live
vaccin
administ
intramuscularli
follow
experiment
intranas
challeng
rsv
week
vaccin
calv
vaccin
inactiv
vaccin
found
complet
protect
rsv
infect
two
live
vaccin
confer
protect
infect
although
reduc
viru
shed
challeng
viru
induc
diseas
control
anim
rsv
vaccin
becom
avail
recent
time
impact
vaccin
program
use
current
avail
pi
viru
rsv
vaccin
calf
pneumonia
assess
overcom
problem
colostr
antibodi
interfer
young
calv
may
necessari
develop
live
intranas
inactiv
rsv
vaccin
preliminari
result
mention
previous
inactiv
rsv
vaccin
base
glutaraldehydefix
cell
particularli
encourag
trial
necessari
howev
vaccin
yet
commerci
avail
futur
epidemiolog
pathogenet
studi
may
reveal
necessari
increas
spectrum
viru
vaccin
prophylaxi
calf
pneumonia
includ
agent
bvd
viru
adenovirus
recent
recogn
respiratori
viru
infect
calf
coronaviru
even
allow
success
immunoprophylaxi
viral
respiratori
diseas
also
rememb
bovi
dispar
ureaplasma
also
shown
capabl
produc
primari
pneumonia
calf
albeit
limit
extent
clinic
sever
order
achiev
complet
control
calf
pneumonia
mycoplasma
vaccin
may
also
use
although
commerci
avail
present
experiment
bovi
dispar
vaccin
produc
consist
formalinkil
organ
oil
adjuv
confer
protect
experiment
challeng
bovi
dispar
vaccin
bacteria
major
bacteria
calf
pneumonia
includ
pasteurella
sp
c
pyogen
appear
act
mainli
secondari
invad
hope
primari
viral
mycoplasm
damag
lung
could
abolish
effect
would
neutral
howev
incid
h
somnu
associ
pneumonia
vaccin
may
consid
h
somnu
capabl
act
signific
primari
lung
pathogen
oral
administr
antibiot
tylosin
tartrat
tetracyclin
use
prophylact
measur
calf
pneumonia
reduc
clinic
sever
mortal
rate
incid
sever
lung
lesion
certain
instanc
unsatisfactori
method
prophylaxi
follow
reason
firstli
antibiot
prevent
viral
respiratori
tract
damag
secondli
although
frequenc
isol
mycoplasma
sp
p
multocida
reduc
infect
elimin
respiratori
tract
lung
lesion
prevent
thirdli
longterm
oral
administr
antibiot
facilit
emerg
antibioticresist
bacteria
like
interfer
develop
normal
rumin
bacteri
flora
use
interferon
induc
direct
use
bovin
interferon
tool
prophylaxi
treatment
calf
pneumonia
interest
possibl
futur
howev
much
vitro
vivo
research
requir
full
potenti
approach
assess
